Pulmonary Medicine - Global Oncology Academy

33-48 of 72

The SMART Protocol in Mesothelioma: Challenges and Opportunities for Global Adoption
The SMART Protocol in Mesothelioma: Challenges and Opportunities for Global Adoption
Project Oncology®
The SMART Protocol in Mesothelioma: Challenges and Opportunities for Global Adoption
John Cho, MD, PhD, FRCPC
- John Cho, MD, PhD, FRCPC
Unlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer
Unlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer
Project Oncology®
Unlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer
Paola Marignani, PhD, EMBA
- Paola Marignani, PhD, EMBA
Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing
Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing
Project Oncology®
Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing
John Cho, MD, PhD, FRCPC
- John Cho, MD, PhD, FRCPC
Addressing Psychological Distress in Lung Cancer: The Emerging Role of EMDR Therapy
Addressing Psychological Distress in Lung Cancer: The Emerging Role of EMDR Therapy
Project Oncology®
Addressing Psychological Distress in Lung Cancer: The Emerging Role of EMDR Therapy
Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Project Oncology®
Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Diagnosing and Staging Non-Small Cell Lung Cancer: Key Updates and Evolving Strategies
Diagnosing and Staging Non-Small Cell Lung Cancer: Key Updates and Evolving Strategies
Global Oncology Academy
Diagnosing and Staging Non-Small Cell Lung Cancer: Key Updates and Evolving Strategies
Gerard A. Silvestri MD, MS, Master FCCP; Jeffrey B. Velotta, MD, FACS
- Gerard A. Silvestri MD, MS, Master FCCP
- Jeffrey B. Velotta, MD, FACS
- Anne Gonzalez, MD, M.Sc.
Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
Project Oncology®
Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
Balazs Halmos, MD, MS
- Balazs Halmos, MD, MS
Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
Project Oncology®
Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
Balazs Halmos, MD, MS
- Balazs Halmos, MD, MS
Optimizing NSCLC Care: Advances in Lung Biopsy and Biomarker Testing
Optimizing NSCLC Care: Advances in Lung Biopsy and Biomarker Testing
Global Oncology Academy
Optimizing NSCLC Care: Advances in Lung Biopsy and Biomarker Testing
Gerard A. Silvestri MD, MS, Master FCCP; Fabien Maldonado, MD, FCCP
- Gerard A. Silvestri MD, MS, Master FCCP
- Fabien Maldonado, MD, FCCP
- Adam H. Fox, MD, MSc
Subcutaneous Pembrolizumab in mNSCLC: A Potential Shift in the Delivery Landscape
Subcutaneous Pembrolizumab in mNSCLC: A Potential Shift in the Delivery Landscape
Project Oncology®
Subcutaneous Pembrolizumab in mNSCLC: A Potential Shift in the Delivery Landscape
Diagnosing LCNEC of the Lung: Challenges and Strategies
Diagnosing LCNEC of the Lung: Challenges and Strategies
Project Oncology®
Diagnosing LCNEC of the Lung: Challenges and Strategies
Junaid Arshad, MD, MS
- Junaid Arshad, MD, MS
Optimizing Nivolumab in NSCLC: Implications for Cost, Access, and Outcomes
Optimizing Nivolumab in NSCLC: Implications for Cost, Access, and Outcomes
Project Oncology®
Optimizing Nivolumab in NSCLC: Implications for Cost, Access, and Outcomes
Aline Fares, MD
- Aline Fares, MD
Investigating At-Home Subcutaneous Atezolizumab for NSCLC: An Ongoing Study
Investigating At-Home Subcutaneous Atezolizumab for NSCLC: An Ongoing Study
Project Oncology®
Investigating At-Home Subcutaneous Atezolizumab for NSCLC: An Ongoing Study
Jorge Nieva, MD
- Jorge Nieva, MD
Stratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
Stratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
Project Oncology®
Stratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
Project Oncology®
Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
Understanding Extensive-Stage Small Cell Lung Cancer: Advancements and Ongoing Challenges
Understanding Extensive-Stage Small Cell Lung Cancer: Advancements and Ongoing Challenges
Global Oncology Academy
Understanding Extensive-Stage Small Cell Lung Cancer: Advancements and Ongoing Challenges
Gerard A. Silvestri MD, MS, Master FCCP; Anurag Singh, MD
- Gerard A. Silvestri MD, MS, Master FCCP
- Anurag Singh, MD
- Adam H. Fox, MD, MSc
- Mariam Alexander, MD, PhD

3/5